Cagrilintide is a long?acting amylin receptor agonist synthetic peptide. It is an analog of human amylin with structural modifications to prolong circulation half?life. It acts on amylin receptors to participate in pre?clinical research related to satiety, food intake, gastric emptying and body weight regulation.

This peptide is widely used in pre?clinical studies covering obesity research, energy balance, glucose homeostasis, appetite control and metabolic disorder animal models. It can be applied for cell?level assays and in?vivo animal model experiments.

Our Cagrilintide is manufactured by mature solid?phase peptide synthesis process. Each batch is strictly analyzed by HPLC and mass spectrometry to confirm high purity and accurate molecular identity. COA is available upon customer request. The lyophilized powder form provides great stability during transportation and long?term preservation. Various packaging specifications are supported, from small lab sample vials to bulk kilogram?level orders.

Warning: This product is exclusively for scientific laboratory research. It shall not be used for human consumption, injection, clinical diagnosis or therapy.

Ready for Gedai chemical website upload. Tell me next peptide name.